Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Finasteride after thulium laser prostate resection for wound healing and complication prevention
ChiCTR1900021072Phase 4Recruiting
- Sponsor
- Shanghai General Hospital
- Start
- Jan 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of finasteride in benign prostatic hyperplasia (BPH) (2 arms), sponsored by Shanghai General Hospital. Primary endpoint: Postoperative complications. Started Jan 2018; status: recruiting.
02
Drugs
finasteride
03
Conditions
benign prostatic hyperplasia (BPH)
Beyond the preview
Go deeper on ChiCTR1900021072.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR1900021072.